Certified by Founder Lodge
Goldman Sachs Asset Management
United Kingdom - London, England
INVESTOR
1 Disclosed Funding Rounds $35,000,000
35 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Bringing together traditional and alternative investments, we provide clients around the world with a dedicated partnership and focus on long-term performance. As the primary investing area w
| Company | Date | Round | Raised |
|---|---|---|---|
 Limble CMMS |
June, 22 ,2023 | Series B | $58,000,000 |
 Resilia |
October, 31 ,2022 | Series B | $35,000,000 |
 Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
 Mews |
December, 16 ,2022 | Series C | $185,000,000 |
 Fortanix |
September, 15 ,2022 | Series C | $90,000,000 |
 Bowery Valuation |
July, 19 ,2023 | Series B | $16,300,000 |
 Netskope |
January, 06 ,2023 | Debt Round | $401,000,000 |
 Solink |
July, 26 ,2023 | Series C | $60,000,000 |
 Mayvenn |
July, 13 ,2022 | Series C | $40,000,000 |
 Candex |
November, 30 ,2023 | Series B | $45,000,000 |
 Zilch |
June, 30 ,2022 | Series C | $50,000,000 |
 Bastille |
January, 26 ,2024 | Series C | $44,000,000 |
 AlphaSense |
June, 15 ,2022 | Series D | $225,000,000 |
 Alterome Therapeutics, Inc |
April, 09 ,2024 | Series B | $132,000,000 |
 MoEngage |
June, 01 ,2022 | Series E | $77,000,000 |
 RippleMatch |
June, 12 ,2022 | Series B | $45,000,000 |
 Kontakt.io |
April, 19 ,2024 | Unknown | $47,500,000 |
 Rimac Technology |
June, 02 ,2022 | Series D | $536,000,000 |
 Vicebio |
September, 24 ,2024 | Series B | $100,000,000 |
 WSO2 |
May, 25 ,2022 | Series E | $3,000,000 |
 Desia |
October, 01 ,2024 | Pre-Seed | $3,300,000 |
 Caribou |
May, 23 ,2022 | Series C | $115,000,000 |
 Mahmee |
May, 12 ,2022 | Series A | $9,200,000 |
 Impact Nano |
May, 08 ,2023 | Unknown | $32,000,000 |
 Madhive |
June, 16 ,2023 | Unknown | $300,000,000 |
| Limble CMMS |
June, 22 ,2023 | Series B | $58,000,000 |
| Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
| Bowery Valuation |
July, 19 ,2023 | Series B | $16,300,000 |
| Solink |
July, 26 ,2023 | Series C | $60,000,000 |
| Candex |
November, 30 ,2023 | Series B | $45,000,000 |
| Bastille |
January, 26 ,2024 | Series C | $44,000,000 |
| Alterome Therapeutics, Inc |
April, 09 ,2024 | Series B | $132,000,000 |
| Kontakt.io |
April, 19 ,2024 | Unknown | $47,500,000 |
| Vicebio |
September, 24 ,2024 | Series B | $100,000,000 |
| Desia |
October, 01 ,2024 | Pre-Seed | $3,300,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
